Prescription drug · ANDA
Cafergot (Ergotamine tartrate and caffeine) NDC 73352-917
Ergotamine tartrate 1 mg/1; Caffeine 100 mg/1 · Tablet, Film coated · Oral · Trifluent Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73352-917-40 | 73352091740 | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (73352-917-40)Marketed from Mar 23, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cafergot
- Generic name (nonproprietary)
- ergotamine tartrate and caffeine
- Active ingredients
- Ergotamine tartrate — 1 mg/1Caffeine — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Trifluent Pharma, LLCNDC labeler code 73352
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040590
- Marketing start
- Listing expires
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)Ergotamines (Chemical structure)Xanthines (Chemical structure)
- Identifiers
- Product ID 73352-917_4db7f801-0dea-0ec8-e063-6294a90a2636SPL ID 4db7f801-0dea-0ec8-e063-6294a90a2636SPL set ID 4db7eece-2eef-bc1b-e063-6394a90a98cbRxCUI 1293504, 1293506UNII MRU5XH3B48, 3G6A5W338EUPC 0373352917402
- Pharmacologic class
- Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473352091740followed by a unit qualifier and the quantityPackage 73352-0917-40. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Ergotamine tartrate and caffeine tablets are indicated as therapy to abort or prevent vascular headache; e.g., migraine, migraine variants or so-called “histaminic cephalalgia.”
Excerpt only. Read the full label for complete information.
About NDC 73352-917
- What is NDC 73352-917?
- 73352-917 is the product NDC for Cafergot, Ergotamine tartrate 1 mg/1; Caffeine 100 mg/1 tablet, film coated, listed with the FDA by Trifluent Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cafergot (Ergotamine tartrate and caffeine).
- What is the active ingredient?
- Ergotamine tartrate, Caffeine.
- Who is the labeler?
- Trifluent Pharma, LLC, NDC labeler code 73352. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cafergot?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 040590
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| ergotamine tartrate and caffeine | Ergotamine tartrate 1 mg/1; Caffeine 100 mg/1 | Tablet, Film coatedOral | Cintex Services, LLC | 24470-917 |